Inhibition of aminopeptidase N (AP-N) and urokinase-type plasminogen activator (uPA) by zinc suppresses the invasion activity in human urological cancer cells
- PMID: 11256475
- DOI: 10.1248/bpb.24.226
Inhibition of aminopeptidase N (AP-N) and urokinase-type plasminogen activator (uPA) by zinc suppresses the invasion activity in human urological cancer cells
Abstract
Zinc is an essential heavy metal and is more abundant in human prostate and kidney than in other tissues. The effects of zinc on the invasion activity of human prostate and renal cancer cell lines, PC-3, LNCaP and SKRC-1, were investigated in vitro using a Transwell cell-culture chamber and were compared with specific protease inhibitors for MMPs, uPA and AP-N, respectively. The invasion activity of PC-3 cells was effectively suppressed by zinc and by all protease inhibitors in a dose-dependent manner. The invasion activity of LNCaP cells was almost unaffected by these inhibitors. In SKRC-1 cells, the invasion activity was strongly suppressed by MP03, although a moderate inhibition by zinc and bestatin was observed. The purified AP-N activity was strongly inhibited by zinc at a concentration similar to that suppressing the invasion activity of PC-3 cells and this inhibition by zinc was apparently competitive. Although the purified uPA activity was also inhibited by zinc, this inhibition was uncompetitive. AP-N was expressed abundantly on the membrane fraction of PC-3 cells among these cells tested, while its expression on the membrane fraction of SKRC-1 cells was weaker than that of PC-3 cells. The expression of uPA was also highest on the membrane fraction of PC-3 cells. These results suggest that AP-N and uPA may be involved in the invasion of human prostate cancer cells and that zinc probably participates in the invasion and metastasis of cancer cells through the regulation of the enzymatic activity of AP-N and uPA in human cancerous prostate.
Similar articles
-
Extract from Serenoa repens suppresses the invasion activity of human urological cancer cells by inhibiting urokinase-type plasminogen activator.Biol Pharm Bull. 2001 Feb;24(2):188-90. doi: 10.1248/bpb.24.188. Biol Pharm Bull. 2001. PMID: 11217090
-
Aminopeptidase N regulated by zinc in human prostate participates in tumor cell invasion.Int J Cancer. 2001 Apr 1;92(1):49-54. Int J Cancer. 2001. PMID: 11279605
-
The surface of prostate carcinoma DU145 cells mediates the inhibition of urokinase-type plasminogen activator by maspin.Cancer Res. 2000 Sep 1;60(17):4771-8. Cancer Res. 2000. PMID: 10987285
-
[Mechanism of tumor cell-induced extracellular matrix degradation--inhibition of cell-surface proteolytic activity might have a therapeutic effect on tumor cell invasion and metastasis].Nihon Sanka Fujinka Gakkai Zasshi. 1996 Aug;48(8):623-32. Nihon Sanka Fujinka Gakkai Zasshi. 1996. PMID: 8808830 Review. Japanese.
-
[Effect of bisphosphonates on anticancer activity in prostate cancer cells].Yakugaku Zasshi. 2012;132(9):1025-30. doi: 10.1248/yakushi.132.1025. Yakugaku Zasshi. 2012. PMID: 23023419 Review. Japanese.
Cited by
-
Exploring ligand dissociation pathways from aminopeptidase N using random acceleration molecular dynamics simulation.J Mol Model. 2016 Oct;22(10):236. doi: 10.1007/s00894-016-3105-y. Epub 2016 Sep 13. J Mol Model. 2016. PMID: 27624165
-
Natural and synthetic inhibitors of kallikrein-related peptidases (KLKs).Biochimie. 2010 Nov;92(11):1546-67. doi: 10.1016/j.biochi.2010.06.022. Epub 2010 Jul 6. Biochimie. 2010. PMID: 20615447 Free PMC article. Review.
-
Metal ion chelation enhances tissue plasminogen activator (tPA)-induced thrombolysis: an in vitro and in vivo study.J Thromb Thrombolysis. 2022 Feb;53(2):291-301. doi: 10.1007/s11239-021-02600-6. Epub 2021 Nov 10. J Thromb Thrombolysis. 2022. PMID: 34757546 Free PMC article.
-
In Vivo Molecular Imaging of the Efficacy of Aminopeptidase N (APN/CD13) Receptor Inhibitor Treatment on Experimental Tumors Using 68Ga-NODAGA-c(NGR) Peptide.Biomed Res Int. 2021 Mar 10;2021:6642973. doi: 10.1155/2021/6642973. eCollection 2021. Biomed Res Int. 2021. PMID: 33778075 Free PMC article.
-
Activity screening and structure-activity relationship of the hit compounds targeting APN/CD13.Fundam Clin Pharmacol. 2011 Apr;25(2):217-28. doi: 10.1111/j.1472-8206.2010.00844.x. Fundam Clin Pharmacol. 2011. PMID: 20636366 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous